Dow Down1.40% Nasdaq Down1.59%

Perrigo Company Public Limited Company (PRGO)

-NYSE
149.18 1.01(0.67%) Oct 1, 4:06PM EDT
|After Hours : 149.18 0.00 (0.00%) Oct 1, 4:40PM EDT
ProfileGet Profile for:
Perrigo Company Public Limited Company
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland - Map
Phone: 353 1 604 0031
Website: http://www.perrigo.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Related Products
Full Time Employees:10,220

Business Summary 

Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company’s Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company’s API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Perrigo Company Public Limited Company

Corporate Governance 
Perrigo Company Public Limited Company’s ISS Governance QuickScore as of Oct 1, 2014 is 5. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 2; Compensation: 6.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Joseph C. Papa , 58
Chairman, Chief Exec. Officer and Pres
2.19M9.59M
Ms. Judy L. Brown , 46
Chief Financial Officer, Principal Accounting Officer and Exec. VP
905.00K1.38M
Mr. Todd W. Kingma , 54
Exec. VP, Gen. Counsel and Sec.
763.00K1.24M
Mr. John T. Hendrickson , 51
Exec. VP of Global Operations and Supply Chain
772.00K601.00K
Mr. Sharon Kochan , 46
Exec. VP and Gen. Mang. of International
740.00K620.00K
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders